You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Drug of choice in chronically hypeensive pregnant women requiring long term antihypeensive therapy: September 2007 and explain in detail?
Ans. C: Methyldopa Methyldopa is a drug of first choice for control of mild to moderate hypeension in pregnancy and is the most widely prescribed antihypeensive for this indication. During long term use in pregnancy, methyldopa does not alter maternal cardiac output or blood flow to the uterus or kidneys, and for all these reasons it is generally considered the agent of choice for chronic blood pressure control in pregnancy. Because the safety record of labetalol in pregnancy is not as well established as that of methyldopa, labetalol should probably be considered a second-line agent for pregnant women with chronic hypeension requiring long term drug therapy